SG Americas Securities’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-44,000
Closed -$251K 2886
2024
Q1
$251K Hold
44,000
﹤0.01% 1812
2023
Q4
$59K Hold
44,000
﹤0.01% 2894
2023
Q3
$46K Buy
+44,000
New +$2.31M ﹤0.01% 2955
2020
Q4
Sell
-248,000
Closed -$45K 3339
2020
Q3
$45K Buy
248,000
+57,500
+30% +$2.22M ﹤0.01% 2530
2020
Q2
$14K Buy
190,500
+140,500
+281% +$5.06M ﹤0.01% 3621
2020
Q1
$2K Sell
50,000
-30,000
-38% -$1.17M ﹤0.01% 3394
2019
Q4
$69K Buy
+80,000
New +$3.35M ﹤0.01% 3020
2019
Q1
Sell
-75,000
Closed -$88K 3369
2018
Q4
$88K Hold
75,000
﹤0.01% 2746
2018
Q3
$360K Hold
75,000
﹤0.01% 2283
2018
Q2
$131K Hold
75,000
﹤0.01% 2899
2018
Q1
$38K Hold
75,000
﹤0.01% 3116
2017
Q4
$26K Buy
+75,000
New +$2.07M ﹤0.01% 3036
2013
Q4
Sell
-200,000
Closed -$14K 2679
2013
Q3
$14K Buy
+200,000
New +$2.16M ﹤0.01% 2901

Other funds holding BSX

SG Americas Securities's BSX Position: Q1 2026 in Review

SG Americas Securities increased its Boston Scientific (BSX) stake by 141% in Q1 2026, buying an estimated $43.6M and bringing the position to 931,155 shares worth $58.4M. The position accounts for 0.06% of the portfolio, ranked #249.

SG Americas Securities first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • SG Americas Securities held 931,155 shares of Boston Scientific worth $58.4M as of Q1 2026.
  • SG Americas Securities bought 544,637 Boston Scientific shares in Q1 2026, an estimated $43.6M.
  • Boston Scientific made up 0.06% of SG Americas Securities's portfolio in Q1 2026, its #249 holding.
  • SG Americas Securities first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.